Functional and structural outcomes in paediatric myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): a prospective study.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Documenta ophthalmologica. Advances in ophthalmology

• Publication date

  2026-02-19

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10633-026-10082-1PMID 41708951
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• ISCEV standard for clinical visual evoked potentials (2025 update)

  2025cited by this paper
• Multi-channel pattern VEPs with full and half field stimulation: methods of interpretation and diagnostic evaluation

  2025cited by this paper
• Diagnostic Value of Inter-Eye Difference Metrics on OCT for Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis

  2024cited by this paper
• The influence of MOGAD on diagnosis of multiple sclerosis using MRI

  2024cited by this paper
• Visual evoked potential in myelin oligodendrocyte glycoprotein antibody-associated disease

  2024cited by this paper
• MOGAD: A comprehensive review of clinicoradiological features, therapy and outcomes in 4699 patients globally.

  2024cited by this paper
• MOG antibody-associated optic neuritis

  2024cited by this paper
• Pathophysiology of myelin oligodendrocyte glycoprotein antibody disease

  2023cited by this paper
• Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide

  2023cited by this paper
• Updates in NMOSD and MOGAD Diagnosis and Treatment: A Tale of Two Central Nervous System Autoimmune Inflammatory Disorders.

  2023cited by this paper
• Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD): current understanding and challenges

  2023cited by this paper
• Attack phenotypes and disease course in pediatric MOGAD

  2023cited by this paper
• Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: International MOGAD Panel proposed criteria.

  2023cited by this paper
• Longitudinal Retinal Changes in MOGAD

  2022cited by this paper
• Neuro-ophthalmological Presentation of Optic Neuritis in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease

  2022cited by this paper
• More Efficient Complement Activation by Anti–Aquaporin-4 Compared With Anti–Myelin Oligodendrocyte Glycoprotein Antibodies

  2022cited by this paper
• Structure–function correlates of vision loss in neuromyelitis optica spectrum disorders

  2022cited by this paper
• OCT retinal nerve fiber layer thickness differentiates acute optic neuritis from MOG antibody-associated disease and Multiple Sclerosis: RNFL thickening in acute optic neuritis from MOGAD vs MS.

  2022cited by this paper
• What can visual electrophysiology tell about possible visual-field defects in paediatric patients

  2021cited by this paper
• Age-dependent favorable visual recovery despite significant retinal atrophy in pediatric MOGAD: how much retina do you really need to see well?

  2021cited by this paper
• Clinical electrophysiology of the optic nerve and retinal ganglion cells

  2021cited by this paper
• Myelin-oligodendrocyte glycoprotein antibody-associated disease.

  2021cited by this paper
• Comparison of Spinal Cord Magnetic Resonance Imaging Features Among Children With Acquired Demyelinating Syndromes

  2021cited by this paper
• Temporal Dynamics of MOG Antibodies in Children With Acquired Demyelinating Syndrome

  2021cited by this paper
• Optical coherence tomography in multiple sclerosis: A 3‐year prospective multicenter study

  2021cited by this paper
• Frequency of New Silent MRI Lesions in Myelin Oligodendrocyte Glycoprotein Antibody Disease and Aquaporin-4 Antibody Neuromyelitis Optica Spectrum Disorder

  2021cited by this paper
• E.U. paediatric MOG consortium consensus: Part 4 - Outcome of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

  2020cited by this paper
• Aquaporin-4 IgG seropositivity is associated with worse visual outcomes after optic neuritis than MOG-IgG seropositivity and multiple sclerosis, independent of macular ganglion cell layer thinning

  2020cited by this paper
• Clinical features and risk of relapses in children and adults with MOGAD.

  2020cited by this paper
• E.U. paediatric MOG consortium consensus: Part 1 - Classification of clinical phenotypes of paediatric myelin oligodendrocyte glycoprotein antibody-associated disorders.

  2020cited by this paper
• Altered fovea in AQP4-IgG–seropositive neuromyelitis optica spectrum disorders

  2020cited by this paper
• Bilateral retinal pathology following a first-ever clinical episode of autoimmune optic neuritis

  2020cited by this paper
• High association of MOG-IgG antibodies in children with bilateral optic neuritis.

  2020cited by this paper
• In vivo structural and functional assessment of optic nerve damage in neuromyelitis optica spectrum disorders and multiple sclerosis

  2019cited by this paper
• Clinical Features and Outcomes of Pediatric Monophasic and Recurrent Idiopathic Optic Neuritis

  2019cited by this paper
• Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.

  2019cited by this paper
• Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome

  2018cited by this paper
• VEP and PERG in patients with multiple sclerosis, with and without a history of optic neuritis

  2017cited by this paper
• ISCEV standard for clinical visual evoked potentials: (2016 update)

  2016cited by this paper
• Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

  2015cited by this paper
• Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis

  2014cited by this paper
• Agreement among spectral-domain optical coherence tomography instruments for assessing retinal nerve fiber layer thickness.

  2011cited by this paper
• Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

  2010cited by this paper
• Receiver operating characteristic curves and their use in radiology.

  2003cited by this paper
• Optic neuritis in children – clinical and electrophysiological follow-up

  2003cited by this paper
• Use of the Mollon-Reffin minimalist color vision test with young children.

  2000cited by this paper
• Applied Logistic Regression, Second Edition

  1989cited by this paper
• The meaning and use of the area under a receiver operating characteristic (ROC) curve.

  1982cited by this paper

• No citing papers are available for this paper.